<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d241">
    <sentence id="DDI-DrugBank.d241.s0" text="Additional reductions in blood pressure may occur when FLOLAN is administered with diuretics, antihypertensive agents, or other vasodilators.">
        <entity id="DDI-DrugBank.d241.s0.e0" charOffset="55-60"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s0.e1" charOffset="83-91"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d241.s0.e2" charOffset="94-116"
            type="group" text="antihypertensive agents"/>
        <entity id="DDI-DrugBank.d241.s0.e3" charOffset="128-139"
            type="group" text="vasodilators"/>
        <ddi id="DDI-DrugBank.d241.s0.d0" e1="DDI-DrugBank.d241.s0.e0"
            e2="DDI-DrugBank.d241.s0.e1" type="effect"/>
        <ddi id="DDI-DrugBank.d241.s0.d1" e1="DDI-DrugBank.d241.s0.e0"
            e2="DDI-DrugBank.d241.s0.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d241.s0.d2" e1="DDI-DrugBank.d241.s0.e0"
            e2="DDI-DrugBank.d241.s0.e3" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s1" text="When other antiplatelet agents or anticoagulants are used concomitantly, there is the potential for FLOLAN to increase the risk of bleeding.">
        <entity id="DDI-DrugBank.d241.s1.e0" charOffset="11-29"
            type="group" text="antiplatelet agents"/>
        <entity id="DDI-DrugBank.d241.s1.e1" charOffset="34-47"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d241.s1.e2" charOffset="100-105"
            type="brand" text="FLOLAN"/>
        <ddi id="DDI-DrugBank.d241.s1.d0" e1="DDI-DrugBank.d241.s1.e0"
            e2="DDI-DrugBank.d241.s1.e2" type="effect"/>
        <ddi id="DDI-DrugBank.d241.s1.d1" e1="DDI-DrugBank.d241.s1.e1"
            e2="DDI-DrugBank.d241.s1.e2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s2" text="However, patients receiving infusions of FLOLAN in clinical trials were maintained on anticoagulants without evidence of increased bleeding.">
        <entity id="DDI-DrugBank.d241.s2.e0" charOffset="41-46"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s2.e1" charOffset="86-99"
            type="group" text="anticoagulants"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s3" text="In clinical trials, FLOLAN was used with digoxin, diuretics, anticoagulants, oral vasodilators, and supplemental oxygen.In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n = 23) and digoxin (n = 30) were decreased by 13% and 15%, respectively, on the second day of therapy and had returned to baseline values by day 87.">
        <entity id="DDI-DrugBank.d241.s3.e0" charOffset="20-25"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s3.e1" charOffset="41-47"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s3.e2" charOffset="50-58"
            type="group" text="diuretics"/>
        <entity id="DDI-DrugBank.d241.s3.e3" charOffset="61-74"
            type="group" text="anticoagulants"/>
        <entity id="DDI-DrugBank.d241.s3.e4" charOffset="82-93"
            type="group" text="vasodilators"/>
        <entity id="DDI-DrugBank.d241.s3.e5" charOffset="113-118"
            type="drug" text="oxygen"/>
        <entity id="DDI-DrugBank.d241.s3.e6" charOffset="202-211"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d241.s3.e7" charOffset="216-222"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s3.e8" charOffset="245-250"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s3.e9" charOffset="302-311"
            type="drug" text="furosemide"/>
        <entity id="DDI-DrugBank.d241.s3.e10" charOffset="326-332"
            type="drug" text="digoxin"/>
        <ddi id="DDI-DrugBank.d241.s3.d0" e1="DDI-DrugBank.d241.s3.e6"
            e2="DDI-DrugBank.d241.s3.e8" type="mechanism"/>
        <ddi id="DDI-DrugBank.d241.s3.d1" e1="DDI-DrugBank.d241.s3.e7"
            e2="DDI-DrugBank.d241.s3.e8" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s4" text="The change in furosemide clearance value is not likely to be clinically significant.">
        <entity id="DDI-DrugBank.d241.s4.e0" charOffset="14-23"
            type="drug" text="furosemide"/>
    </sentence>
    <sentence id="DDI-DrugBank.d241.s5" text="However, patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with FLOLAN, which may be clinically significant in patients prone to digoxin toxicity.">
        <entity id="DDI-DrugBank.d241.s5.e0" charOffset="21-27"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s5.e1" charOffset="52-58"
            type="drug" text="digoxin"/>
        <entity id="DDI-DrugBank.d241.s5.e2" charOffset="108-113"
            type="brand" text="FLOLAN"/>
        <entity id="DDI-DrugBank.d241.s5.e3" charOffset="173-179"
            type="drug" text="digoxin"/>
        <ddi id="DDI-DrugBank.d241.s5.d0" e1="DDI-DrugBank.d241.s5.e0"
            e2="DDI-DrugBank.d241.s5.e2" type="mechanism"/>
    </sentence>
</document>
